Skip to main content
. 2020 Aug 31;15(8):e0238388. doi: 10.1371/journal.pone.0238388

Fig 2. Comparison of the prevalence of NAFLD and NAFLD having elevation of ALT among the Non-MS, Pre-MS, and MS groups.

Fig 2

A Comparison of the prevalence of NAFLD among the Non-MS, Pre-MS, and MS groups. B Comparison of the prevalence of NAFLD having elevation of ALT among the Non-MS, Pre-MS, and MS groups. The gray bar indicates the prevalence of NAFLD. The black bar indicates the prevalence of NAFLD having elevation of ALT. ALT, alanine aminotransferase; MS, metabolic syndrome; NAFLD, nonalcoholic fatty liver disease; *P < 0.001.